This study is in progress, not accepting new patients
A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)
Summary
- Eligibility
- for people ages 41-86 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Transposon Therapeutics, Inc.
- ID
- NCT04993768
- Phase
- Phase 2 Progressive Supranuclear Palsy Research Study
- Study Type
- Interventional
- Participants
- Expecting 40 study participants
- Last Updated